Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Rapidly is the Yellow Fever Vaccine Market Expected to Expand Between 2025 and 2034 Based on Current Trends?

The market size for yellow fever vaccines has seen robust growth in recent years. It is projected to expand from $4.54 billion in 2024 to $4.79 billion in 2025, with a compound annual growth rate (CAGR) of 5.4%. Factors contributing to to this growth in the historical period include the commencement of worldwide immunization drives, enforcement of global health policies, extensive vaccination initiatives, and advancements in vaccine manufacturing technology.

In the upcoming years, the market size for the yellow fever vaccine is predicted to experience robust growth, eventually reaching $5.84 billion in 2029 with a compound annual growth rate (CAGR) of 5.1%. This growth over the forecast period can be credited to factors such as enhanced collaborations and partnerships, incorporation into regular vaccination schedules, increased surveillance and monitoring, a growing role of the private sector, and application of digital technologies to track vaccines. Key market trends anticipated during this forecast period include the diversified formats of vaccines, readiness for pandemics, regulatory modifications, advancements in healthcare infrastructure, and heightened consumer understanding and awareness.

What Major Innovations Are Driving the Accelerated Growth of the Yellow Fever Vaccine Market?

The yellow fever vaccine market is anticipated to be bolstered by the rise in international travel. Defined as the crossing of national boundaries by individuals for reasons such as tourism, business, or personal affairs, international travel is witnessing a surge due to an increase in global connectivity, economic expansion, and the easing of travel restrictions following the pandemic. It is either mandatory or advised for travelers journeying to areas where yellow fever is prevalent to get vaccinated to avoid infection and adhere to global health guidelines. This was exemplified in January 2024 when, as reported by the Spain-based World Tourism Organization, the number of international tourists reached 1.286 billion globally in 2023, compared to 960 million in 2022 – an increase of 326 million. As a result, the escalation in international travel is contributing to the rise of the yellow fever vaccine market.

Request Your Free Yellow Fever Vaccine Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

Which Key Players Are Shaping the Future of the Yellow Fever Vaccine Market?

Major companies operating in the yellow fever vaccine market are:

• Merck and Co Inc.

• Sanofi S.A.

• GSK plc

• Takeda Pharmaceutical Company

• Lonza Group Ag

How Are the Latest Trends Influencing the Growth of the Yellow Fever Vaccine Market?

Leading firms in the yellow fever vaccine market are centering their efforts on creating next-generation vaccinations, such as T-cell adaptive booster vaccines, in response to the rising worldwide vaccine demand. These are specialized vaccines meant to augment the memory T-cell response of our immune system, thus providing extended and robust defense against particular pathogens. For example, in April 2022, UK-based biotech firm, Emergex Vaccines Holding Limited, joined forces with ATCC, a non-profit organization based in the US that supplies reference microorganisms, cell lines, and other research and development materials, to launch CD8+ T-cell adaptive vaccines. These are tailored explicitly for yellow fever and are devised to incite a robust cytotoxic T-cell response, crucial for spotting and exterminating virus-infected cells. By fostering the generation of memory CD8+ T-cells, these vaccines bestow enduring and robust immunity. They target the cellular immune response instead of simply antibody production, providing holistic protection against yellow fever and potentially escalating effectiveness in people with varied immune profiles.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

What Are the Major Segments of the Yellow Fever Vaccine Market and Their Role in Driving Growth?

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Treatment Type: Pain Management Drugs, Oral Rehydration

3) By Application: Routine Immunization, Travelers, Other Applications

4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

What Regions Are At the Forefront of Yellow Fever Vaccine Market Expansion?

North America was the largest region in the yellow fever vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Core Features That Define the Yellow Fever Vaccine Market?

The yellow fever vaccine is a live, attenuated viral vaccine used to prevent yellow fever, a serious viral infection transmitted by mosquitoes. It is typically administered as a single dose and provides long-lasting immunity, often lifelong. The vaccine is especially important for people living in or traveling to endemic areas.

Browse Through More Similar Reports By The Business Research Company:

Adult Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Cervical Cancer Vaccine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cervical-cancer-vaccine-global-market-report

Vaccine Adjuvants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: